IFP Advisors, Inc - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$21,323
-58.6%
695
-50.0%
0.00%0.0%
Q2 2023$51,479
+117.9%
1,390
+100.0%
0.00%0.0%
Q1 2023$23,630
+90784.6%
695
-5.6%
0.00%0.0%
Q4 2022$26
-99.9%
736
-20.7%
0.00%0.0%
Q3 2022$36,0000.0%928
+1.2%
0.00%0.0%
Q2 2022$36,000
-40.0%
917
-43.1%
0.00%0.0%
Q1 2022$60,000
+42.9%
1,612
+131.9%
0.00%0.0%
Q4 2021$42,000
+7.7%
6950.0%0.00%0.0%
Q3 2021$39,000
+1850.0%
695
+2680.0%
0.00%
Q2 2021$2,0000.0%250.0%0.00%
Q1 2021$2,000
-77.8%
25
-83.4%
0.00%
Q4 2020$9,000
-88.9%
151
-88.9%
0.00%
-100.0%
Q3 2020$81,0001,3580.01%
Q2 2020$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q4 2018$9,000
+200.0%
200
+100.0%
0.00%
Q4 2016$3,0000.0%1000.0%0.00%
Q3 2016$3,000
-25.0%
100
-9.9%
0.00%
Q2 2016$4,000
-50.0%
111
+11.0%
0.00%
-100.0%
Q4 2015$8,0001000.00%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
GAGNON SECURITIES LLC 563,415$21,753,4534.80%
Gagnon Advisors, LLC 180,331$6,962,5794.70%
Spyglass Capital Management LLC 868,686$33,539,9662.69%
Tamarack Advisers, LP 100,000$3,861,0001.99%
ARMISTICE CAPITAL, LLC 1,892,000$73,050,1201.27%
NEUMEIER POMA INVESTMENT COUNSEL LLC 276,590$10,679,1400.99%
RICE HALL JAMES & ASSOCIATES, LLC 437,285$16,883,5740.97%
Rock Springs Capital Management LP 1,032,600$39,868,6860.96%
OUTFITTER FINANCIAL LLC 25,860$998,4550.91%
Stephens Investment Management Group LLC 1,168,469$45,535,2370.82%
View complete list of PACIRA PHARMACEUTICALS INC shareholders